Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..
2017.
Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..
2017.
Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..
2017.
Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Sansone P, Savini C, Kurelac I, Chang Q, Amato LBenedetta, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L et al..
2017.
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.. Proc Natl Acad Sci U S A. 114(43):E9066-E9075.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..
2017.
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..
2017.
Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Merkler AE, Ch'ang J, Parker WE, Murthy SB, Kamel H.
2017.
The Rate of Complications after Ventriculoperitoneal Shunt Surgery.. World Neurosurg. 98:654-658.
Merkler AE, Ch'ang J, Parker WE, Murthy SB, Kamel H.
2017.
The Rate of Complications after Ventriculoperitoneal Shunt Surgery.. World Neurosurg. 98:654-658.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..
2017.
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..
2017.
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.